Biontech stock forecast 2021
WebJun 3, 2024 · Both companies are also likely to post net margins of upward of 50% this year. Moderna stock trades at about 4x projected 2024 revenues, while BioNTech trades at a slightly lower 3.3x projected ... WebOct 20, 2024 · Over Q1 2024, BioNTech posted revenue of about $2.5 billion, with Net Margins coming in at a solid 55%. However, despite the strong financials, BioNTech …
Biontech stock forecast 2021
Did you know?
WebMay 10, 2024 · BioNTech stock analysts called for $1.77 billion. BioNTech also earned 4.39 euros per share, on an adjusted basis — about $5.34 a share. Income swung from losses in the year-ago period. Analysts ... Web2 days ago · For reference, the global economy was estimated to sit at $96 trillion in 2024 according to estimates from the world bank, so if the IMF's forecast bears fruit, then the economic damage from the ...
WebSee below for BioNTech stock analysis and forecast. This trade was called a few weeks ago, and it was only a couple of weeks ago that the stock reached out entry. The stock price has pulled back to around $233 per share, reacting as expected. BioNTech Stock price. Watch BioNTech’s forecast on the supply and demand technical analysis below. WebAug 3, 2024 · BioNTech SE BNTX is scheduled to report second-quarter 2024 results on Aug 9, before market opens. The company’s earnings surprise record has been mixed so far as its earnings beat the Zacks ...
WebApr 9, 2024 · 13 analysts have issued twelve-month price targets for BioNTech's shares. Their BNTX share price forecasts range from $130.00 to $260.00. On average, they … WebNov 18, 2024 · BNTX stock forecast in the longer term (2024-2025) Though analysts rarely look beyond a 12-month time horizon, Wallet Investor’s forecasts use historical price …
WebAug 23, 2024 · BNTX stock forecast. According to data from CNN Business, BNTX has a median target price of $398.64 which is a premium of only about 5 percent over the current prices. Analysts don’t seem too ...
WebApr 11, 2024 · According to the issued ratings of 13 analysts in the last year, the consensus rating for BioNTech stock is Hold based on the current 7 hold ratings and 6 buy ratings for BNTX. The average twelve-month price prediction for BioNTech is $178.50 with a high price target of $260.00 and a low price target of $130.00. sign in ebay with gmailWebSep 30, 2024 · When I last covered BioNTech back in February, I set a share price forecast of ~$200 for BioNTech stock, but that was based on sales of its Comirnaty COVID vaccine - jointly developed with Pfizer ... the pussicats dolls don\u0027t chaWebSep 29, 2024 · Over Q1 2024, BioNTech posted revenue of about $2.5 billion, with Net Margins coming in at a solid 55%. However, despite the strong financials, BioNTech stock trades at just 6x projected 2024 ... the pussersWebNov 9, 2024 · BioNTech Stock Crumbles After 2024 Outlook Misses By Almost $3 Billion. 3/27/2024 BioNTech said Monday it expects roughly $5.4 billion in sales of its Covid shot this year, missing views and ... sign in edge microsoftWebJun 2, 2024 · Over Q1 2024, BioNTech posted revenue of about $2.5 billion, with Net Margins coming in at a solid 55%. However, despite the strong financials, BioNTech stock trades at just 6x projected 2024 ... the pushy princessWebSee BioNTech SE (BNTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. the pusnisherWeb1 day ago · The global mRNA Vaccines & Therapeutics market size was valued at USD 40960.0 million in 2024 and is expected to expand at a CAGR of -31.55% during the forecast period, reaching USD 4212.75 Email icon sign in edge with google account